Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine Effect on Supraclavicular Block Duration
IRCT201607276280N9Phase 3Completed
- Sponsor
- Research Vice Chancellorship of Guilan University of Medical Sciences
- Start
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexmedetomidine in upper extremity fracture, sponsored by Research Vice Chancellorship of Guilan University of Medical Sciences. Primary endpoint: Duration of supraclavicular block. Started Aug 2016; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
upper extremity fracture
Beyond the preview
Go deeper on IRCT201607276280N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201607276280N9.